Melanoma (Skin) Stage IV Completed Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Stage 4 Melanoma / Melanoma Stage Iv / Stage IV Skin Melanoma / Stage IV Melanoma

IndicationStatusPhase
DBCOND0109891 (Melanoma (Skin) Stage IV)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00397982Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant MelanomaTreatment
NCT00387751Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant MelanomaTreatment
NCT00026221Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant MelanomaTreatment
NCT00255762Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryTreatment